| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/19/2009 | US20090076086 Substituted nicotinamide compounds and uses thereof |
| 03/19/2009 | US20090076085 Deuterium-enriched nicraven |
| 03/19/2009 | US20090076083 Deuterium-enriched saredutant |
| 03/19/2009 | US20090076082 Deuterium-enriched alvimopan |
| 03/19/2009 | US20090076081 Piperidine derivatives as nk3 antagonists |
| 03/19/2009 | US20090076080 Deuterium-enriched fexofenadine |
| 03/19/2009 | US20090076079 Deuterium-enriched methylphenidate |
| 03/19/2009 | US20090076078 New compounds 966 |
| 03/19/2009 | US20090076077 Methods and Compositions for Selectin Inhibition |
| 03/19/2009 | US20090076076 Inhibitors of cysteine proteases and methods of use thereof |
| 03/19/2009 | US20090076075 Quinoline derivatives |
| 03/19/2009 | US20090076074 Quinoline derivatives |
| 03/19/2009 | US20090076073 Therapeutic amides |
| 03/19/2009 | US20090076072 Deuterium-enriched tafenoquine |
| 03/19/2009 | US20090076071 Deuterium-enriched retapamulin |
| 03/19/2009 | US20090076070 Hetero compound |
| 03/19/2009 | US20090076069 Deuterium-enriched apixaban |
| 03/19/2009 | US20090076068 Imidazopyridin-2-one derivatives as inhibitors of lipases and phospholipases |
| 03/19/2009 | US20090076067 Pharmaceutical composition comprising azarhodacyanine compound as active ingredient |
| 03/19/2009 | US20090076066 Deuterium-enriched zolpidem |
| 03/19/2009 | US20090076065 Deuterium-enriched mk-0812 |
| 03/19/2009 | US20090076064 Compounds |
| 03/19/2009 | US20090076063 Carboxamide compound and use of the same |
| 03/19/2009 | US20090076062 Organic Compounds |
| 03/19/2009 | US20090076061 Muscarinic acetycholine receptor antagonists |
| 03/19/2009 | US20090076060 Deuterium-enriched temsirolimus |
| 03/19/2009 | US20090076059 Deuterium-enriched dianicline |
| 03/19/2009 | US20090076058 Deuterium-enriched finasteride |
| 03/19/2009 | US20090076057 Deuterium-enriched dutasteride |
| 03/19/2009 | US20090076056 Deuterium-enriched topotecan |
| 03/19/2009 | US20090076055 Deuterium-enriched vinflunine |
| 03/19/2009 | US20090076054 lysate reagent is added into a sample in the presence of albumin and/or globulin; preparing an injection containing a camptothecin derivative, a timiperone or a taxane derivative and having an endotoxin concentration of less than a specification limit |
| 03/19/2009 | US20090076053 Methods and compositions for treating pain |
| 03/19/2009 | US20090076052 Deuterium-enriched nalmefene |
| 03/19/2009 | US20090076051 Deuterium-enriched methylnaltrexone |
| 03/19/2009 | US20090076050 Synergistic tumor-killing effect of radiation and berberine combined treatment in lung cancer |
| 03/19/2009 | US20090076049 Novel Spiro [Imidazolidine-4, 3' -Indole] 2, 2', 5' (1H) Triones for Treatment of Conditions Associated with Vanilloid Receptor 1 |
| 03/19/2009 | US20090076048 Deuterium-enriched xaliproden |
| 03/19/2009 | US20090076046 Compounds modulating c-fms and/or c-kit activity and uses therefor |
| 03/19/2009 | US20090076045 Non-nucleoside reverse transcriptase inhibitors |
| 03/19/2009 | US20090076044 Vegfr inhibitors containing a zinc binding moiety |
| 03/19/2009 | US20090076043 Deuterium-enriched alfuzosin |
| 03/19/2009 | US20090076042 Deuterium-enriched erlotinib |
| 03/19/2009 | US20090076041 Acyclic nucleoside derivatives |
| 03/19/2009 | US20090076040 Deuterium-enriched valganciclovir |
| 03/19/2009 | US20090076039 Deuterium-enriched valacyclovir |
| 03/19/2009 | US20090076038 Deuterium-enriched entecavir |
| 03/19/2009 | US20090076037 Bicyclic pyrimidine kinase inhibitors |
| 03/19/2009 | US20090076036 Deuterium-enriched risperidone |
| 03/19/2009 | US20090076035 Deuterium-enriched paliperidone |
| 03/19/2009 | US20090076034 Deuterium-enriched bms-690514 |
| 03/19/2009 | US20090076033 Method for treating atherosclerosis employing an aP2 inhibitor and combination |
| 03/19/2009 | US20090076032 Derivatives of 18Beta-Glycyrrhetinic Acid |
| 03/19/2009 | US20090076031 Deuterium-enriched bortezomib |
| 03/19/2009 | US20090076030 Piperazine compounds |
| 03/19/2009 | US20090076029 Compounds and Methods for Treating Obesity |
| 03/19/2009 | US20090076028 Deuterium-enriched itraconazole |
| 03/19/2009 | US20090076027 Deuterium-enriched lurasidone |
| 03/19/2009 | US20090076026 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects of dry-mouth and constipation; biphenyl carbamate derivatives; biphenyl-2-ylcarbamic acid 1-(3-(3-[3-(4-hydroxybenzylamino)propyl]-2-oxoimidazolidin-1-yl)propyl)piperidin-4-yl ester |
| 03/19/2009 | US20090076025 Deuterium-enriched dasatinib |
| 03/19/2009 | US20090076024 Episomal Fusion Gene |
| 03/19/2009 | US20090076023 Local Anesthetic Methods and Kits |
| 03/19/2009 | US20090076022 Tartrate salts of quinazoline based egfr inhibitors containing a zinc binding moiety |
| 03/19/2009 | US20090076021 Therapeutic combinations and methods for cardiovascular improvement and treating cardiovascular disease |
| 03/19/2009 | US20090076020 Cyclopropyl Amide Derivatives 978 |
| 03/19/2009 | US20090076019 Methods for treating neurological disorders or damage |
| 03/19/2009 | US20090076018 Deuterium-enriched ranolazine |
| 03/19/2009 | US20090076017 Deuterium-enriched trabectedin |
| 03/19/2009 | US20090076016 Formulations comprising jorumycin-, renieramycin-, safracin- or saframycin-related compounds for treating proliferative diseases |
| 03/19/2009 | US20090076015 Tricyclic Spiro Compound Comprising Acyl Group Bound to Nitrogen Atom in the Ring |
| 03/19/2009 | US20090076014 For administration with food; bioavailability |
| 03/19/2009 | US20090076013 Deuterium-enriched sitagliptin |
| 03/19/2009 | US20090076012 Modulation of pathogenicity |
| 03/19/2009 | US20090076011 Deuterium-enriched tirapazamine |
| 03/19/2009 | US20090076010 Deuterium-enriched lamotrigine |
| 03/19/2009 | US20090076009 Thiazole derivatives and their use as anti-tumour agents |
| 03/19/2009 | US20090076008 Deuterium-enriched fosaprepitant |
| 03/19/2009 | US20090076007 Deuterium-enriched aprepitant |
| 03/19/2009 | US20090076006 Hsp90 inhibitors containing a zinc binding moiety |
| 03/19/2009 | US20090076005 Kinase inhibitor compounds |
| 03/19/2009 | US20090076004 1-Aryl-or heteroaryl-3-aryl-or heteroarylindole-2-carboxylic acids or esters: e.g., 5-(4-tert-Butylphenyl)-1,3-bis(4-isopropoxyphenyl)-indole-2-carboxylic acid; inhibition of the activity of microsomal prostaglandin E synthase-1, leukotriene C4 and/or 5-lipoxygenase-activating protein; analgesics |
| 03/19/2009 | US20090076003 Phthalazine Derivatives with Angiogenesis Inhibiting Activity |
| 03/19/2009 | US20090076002 Novel amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments |
| 03/19/2009 | US20090076001 Substituted 4,5,6,7 -Tetrahydro-Isoxazolo[4,5-C]Pyridine Compounds and Use Thereof for Producing Medicaments |
| 03/19/2009 | US20090076000 Deuterium-enriched mycophenolate mofetil |
| 03/19/2009 | US20090075999 Oxygen linked pyrimidine derivatives |
| 03/19/2009 | US20090075998 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors |
| 03/19/2009 | US20090075997 Deuterium-enriched satavaptan |
| 03/19/2009 | US20090075996 Heterotetracyclic compounds as tpo mimetics |
| 03/19/2009 | US20090075995 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF |
| 03/19/2009 | US20090075994 Deuterium-enriched radafaxine |
| 03/19/2009 | US20090075993 N-[3-(1 -piperidinyl)propoxy]-pyridin-1-oxide-3-carboxamidine ; increasing vaso-relaxation of a vessel associated with endothelial cells |
| 03/19/2009 | US20090075992 Pteridine Derivatives as Nitric Oxide Synthase Activators |
| 03/19/2009 | US20090075991 Deuterium-enriched efavirenz |
| 03/19/2009 | US20090075990 Aerosol Formulation for Inhalation Containing an Anticholinergic Agent |
| 03/19/2009 | US20090075989 Non-steroidal progesterone receptor modulators |
| 03/19/2009 | US20090075988 phosphodiesterase inhibitors such as 1-[3-(4-fluoro-phenyl-piperazin-1-yl]-6,7-dimethoxy-isoquinoline-4-carbonitrile, having improved solubility, metabolic stability and/or bioavailability, used for the treatment of neurodegenerative diseases, psychological disorders and drug addiction |
| 03/19/2009 | US20090075987 Alkylacetylene substituted acyltryptophanols |
| 03/19/2009 | US20090075986 Anti-inflammatory medicaments |
| 03/19/2009 | US20090075985 Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease |